Ocular Toxicity of Mirvetuximab

Conclusions: Mirvetuximab soravtansine therapy can cause transient corneal toxicity. A short course of topical steroids can reduce the patient symptoms.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research